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D
ifferences in pathophysiology may
affect the diagnosis, prevention, and
treatment of diabetes in Asian Amer-
icans,NativeHawaiians,andPaciﬁcIs l an d -
ers (AANHPIs). Equally important are
differencesinculturalbeliefs,dietaryhabits,
and behavioral patterns among AANHPIs
that require culturally effective translation
ofinterventionsintothecommunity.These
issues were discussed by clinicians and in-
vestigatorsataconferenceheldinHonolulu,
Hawaii,inSeptember2011withthetheme
“Diabetes in Asian Americans, Native
Hawaiians, and Paciﬁc Islanders: A Call
to Action” by a coalition of health care
organizations, clinicians, and scientists
with strong interests in the topic and in
the health of AANHPI populations (1).
The discourse begins with an evaluation
ofpathophysiologicdifferences,followed
byadiscussionofthestandarddiagnostic
criteria and current treatment algorithms
as well as dietary recommendations. The
focus then shifts to various diabetes
prevention studies speciﬁct oA A N H P I s
andtheirrelevancetothisgrowingethnic
minority group in America. This review
concludes with two investigations that
demonstrate culturally appropriate inter-
ventions and a brief description of the
role played by the National Diabetes Ed-
ucation Program (NDEP).
PATHOPHYSIOLOGIC
DIFFERENCES
Pathophysiologydtype 1 diabetes
Diabetes has reached an epidemic level
aroundtheworld,withmostoftheincrease
attributable to type 2 diabetes in develop-
ingAsiancountriessuchasIndiaandChina
(2). Type 1 diabetes is also increasing, al-
though at a much less dramatic rate than
type2diabetesandisnowalsoincreasingly
associated with obesity and insulin resis-
tance (3). The highest rates for type 1 di-
abetesarefoundinNorthernEuropeanand
Scandinavian countries and among the
Caucasian population of the U.S. In con-
trast, type 1 diabetes is approximately 5 to
10 times lower in prevalence in those of
Asian than those of European descent (4).
IntheU.S.,theincidenceoftype1diabetes
islowerbytwo-toﬁvefoldinblacks,Asian
Americans, and Hispanics compared with
Caucasians (5). A study of ethnically di-
verse American children with diabetes
showed that most children aged ,9 years
had typical type 1 diabetes (6). However,
amongchildrenaged10to19years,merely
10% of Caucasian children had type 2 di-
abetesincontrastto40%ofAsianAmerican
and Paciﬁc Islander children (7).
In Caucasians, type 1 diabetes is
closely associated with certain HLA hap-
lotypes, such as DR3/4 and DQB1, and
other genes such as insulin, cytotoxic
t-lymphocyte antigen 4 (INS, CTLA4), but
only;30%ofEastAsiansandAsianAmer-
icans have these genotypes (8). The pres-
ence ofantibodies typicallyassociated with
type1diabeteswasalsolow,lessthan50%
in various East Asian groups (9). The low
occurrenceofDR3andDR4inAsianAmer-
ican children with type 1 diabetes corre-
lated with their low incidence for type 1
diabetes. However, despite the low fre-
quency of the at-risk HLA genotype in
Asians, among siblings who are positive
for the genotype, in Japan for example,
there is an increased rate of developing
type 1 diabetes that is comparable to Cau-
casians (10). Other differences in genetic
markers exist between Asians and Cauca-
sians with type 1 diabetes; for example, a
variant of small ubiquitin-like modiﬁer 4
(SUMO4)wasassociatedwithdiabetesin
East Asians but not in Caucasians (9).
A recent study showed that type 1
diabetes can be difﬁcult to clinically dif-
ferentiate from type 2 diabetes in East
Asian Americans, especially among those
aged ,35 years, because BMI is equally
low, ;24 kg/m
2, in both types (11). This
isverydifferentfromother ethnicgroups,
wheretheBMIsoftype2diabetespatients
areusuallyhighand.27kg/m
2.Howe ver,
type 1 diabetes can be distinguished from
type 2 diabetes in these patients by
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Reviews/Consensus Reports/ADA Statements
REVIEWdifferences in several biochemical param-
eterssuchashigherconcentrationsofHDL
and adiponectin and lower concentrations
ofc-peptideintype1diabetes.Inaddition,
insulin clamp studies showed signiﬁcantly
higher glucose disposal rates, similar to
nondiabetic control subjects in type 1 di-
abetes than in type 2 diabetes, indicating
reduced insulin sensitivity in type 2 dia-
betic patients even with BMIs similar to
Asian Americans with type 1 diabetes.
Low positivity of auto-antibodies at
;30% in Asian American patients with
type 1 diabetes also raises questions about
mechanisms underlying the destruction of
b-cells in this population.
Pathophysiologydtype 2 diabetes
The pathogenesis of type 2 diabetes is
closely associated with increased body
weight, obesity, sedentary lifestyle, inﬂam-
mation, and insulin resistance. However,
the relationship between excess adiposity
and diabetes is not so straightforward in
AANHPIs. Native Hawaiians and other
Paciﬁc Islanders have a higher prevalence
of type 2 diabetes and are predisposed
to obesity. Surprisingly, South Asians
(Indians)andEastAsians(Chinese,Koreans,
and Japanese) typically have a lower mean
BMI and waist circumference but a higher
prevalence of diabetes and other meta-
bolic conditions compared with Cauca-
sians at similar levels of BMI and waist
circumference.
To help explain this paradox, the role
of body composition in diabetes risk was
assessed further in multiple publications
from the Japanese American Community
Diabetes Study, a prospective study of
second- and third-generation Japanese
Americans of 100% Japanese ancestry. Re-
sults of this study have demonstrated the
overridingimportanceofvisceralfatasarisk
factorforadversemetabolicoutcomessuch
as coronary heart disease, hypertension,
impaired glucose tolerance (IGT), type 2
diabetes, metabolic syndrome, and insulin
resistance (12). Visceral fat measured by
computed tomography as intra-abdominal
fat area, in contrast to the abdominal and
thighsubcutaneousfatdepots,waslinearly
and positively associated with the risk of
developing type 2 diabetes over a 10-year
period (13). Several hypotheses have been
advanced to explain this relationship be-
tween visceral fat accumulation and dia-
betes risk, including deposition of free
fatty acids mobilized from visceral fat
into the liver’s portal circulation and the
presence of adipocyte-associated inﬂam-
matory markers (14).
In addition, a cross-sectional com-
parison of Caucasians in Pittsburgh and
nativeJapanesefoundahighermeanvisceral
fat area in each quartile of waist circumfer-
ence that reached statistical signiﬁcance in
twoquartiles(15).Inanothercross-sectional
comparison, Filipino women in California
with a normal Asian-adjusted BMI (,23
kg/m
2) similarly had a greater volume of
intra-abdominal fat compared with white
or African American women also with a
normalBMI(,25kg/m
2)(16).Theavailable
evidence therefore argues that Asian eth-
nicity may be predisposed to greater depo-
sition of fat in the visceral depot.
Little is known about differences in
regional fat distribution in other Asian or
PaciﬁcIslanderorNativeHawaiianethnic
groups. At a BMI cut point of 30 kg/m
2
in European men and women residents
of New Zealand that corresponded to
a mean percentage of body fat by dual
X-ray absorptiometry (DXA) of 28.7%
and42.5%,respectively,the same percent-
ageofbodyfatathigherBMIcutpointswas
found in Maori and Paciﬁc Islander men
(31.3, 34.1) and women (33.1, 35.0) (17).
Differencesinbodycompositionhave
beenexaminedtoexplainvariationintype2
diabetes prevalence by ethnicity. In a logis-
tic model predicting type 2 diabetes prev-
alence by ethnicity among Filipino, white,
and African American women, adjustment
for visceral fat did not explain the higher
odds of diabetes associated with ethnicity,
because Filipino women continued to
have a statistically signiﬁcant 7.51-fold
and 2.30-fold increased odds of diabetes
(16). In that study, ethnic differences in
diabetes prevalence by ethnicity could
not be completely explained by body
composition and other measured life-
style characteristics.
An analysis of the Hawaii component
oftheMultiethnicCohortallowedadirect
comparison of the inﬂuence of excess
body weight and weight change on di-
abetes incidence in Caucasians, Native
Hawaiians, and Japanese Americans
(18,19). After a total follow-up time of
1,119,224 person-years, 11,838 incident
diabetescaseswere identiﬁed,withanan-
nual incidence rate of 10.4/1,000 person-
years. Native Hawaiians had the highest
rate at 15.5, followed by Japanese Amer-
icans (12.5) and Caucasians (5.8); the ad-
justed hazard ratios (HRs) were 2.65 for
Japanese Americans and 1.93 for Native
Hawaiians compared with Caucasians
(18). BMI was positively related to inci-
dence in all ethnic groups (Fig. 1). Com-
paredwiththelowestcategoryofBMI,the
respective HRs at BMIs of 22.0–24.9,
25.0–29.9, and $30.0 kg/m
2 were 2.10,
4.12, and 9.48. The risk was highest for
Japanese Americans and intermediate for
Native Hawaiians in each BMI category.
Similar to the effects of BMI, diabetes risk
was greatest for Japanese Americans, in-
termediate for Native Hawaiians, and
lowest for Caucasians in each weight-gain
category (Fig. 2). The partial population-
attributable risk for BMI in men was 65,
60, and 38% for Caucasians, Native
Hawaiians,andJapaneseAmericans,respec-
t i v e l y ,a n d6 4 ,6 7 ,a n d3 8 %f o rw o m e n ,b u t
the ethnic differences were not statistically
signiﬁcant.
Figure 1dDiabetes risk by BMI category in the Hawaii component of the Multiethnic Cohort
Study. The reference group is Caucasians in the lowest BMI category.
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Pathophysiology and treatment in AANHPIsDIABETES
COMPLICATIONSdIn previous re-
ports, aggregate data for Asians and Pa-
ciﬁc Islanders with health insurance
coverage showed a signiﬁcantly lower
incidence of cardiovascular disease and
lower-extremity amputation (LEA) and
higherend-stagerenaldisease(ESRD)rates
over 2 years of follow-up compared with
Caucasians (20). To obtain disaggregated
data, a prospective cohort study was done
(1996–2006) of 64,211 diabetic patients
enrolled in the Kaiser Permanente North-
ern California Diabetes Registry, including
40,286 Caucasians, 8,668 blacks, 7,763
Latinos, 3,572 Filipinos, 1,823 Chinese,
951 Japanese, 593 Paciﬁc Islanders, and
555 South Asians (21). Incidence rates
were calculated after 7.2 6 3.3 years of
follow-up, and Cox proportional hazard
models were created, adjusted for age, edu-
cational attainment, English proﬁciency,
neighborhood deprivation, BMI, smoking,
alcohol use, exercise, medication adher-
ence, type and duration of diabetes,
HbA1c,hypertension,estimatedglomerular
ﬁltration rate, albuminuria, and LDL cho-
lesterol.Incidencesofmyocardialinfarction
(MI),congestiveheartfailure(CHF),stroke,
ESRD,andLEAwereage-andsex-adjusted.
Presented here are the results of these anal-
yses in the Asian and Paciﬁc Islander
groups, using Caucasians as the reference.
The average BMI was similar for Cau-
casians and Paciﬁc Islanders but lower for
the other four Asian subgroups (Chinese,
Japanese, Filipino, and South Asian). The
aggregatedunadjustedAsianincidencerate
(95% CI) for MI of 10.8/1,000 person-
years (9.9–11.8) was lower than the rate in
Caucasians of 17.1 (16.6–17.7) but ob-
scured the wide range of rates across the
four Asian groups, which were Chinese,
9.2; Japanese, 10.5; Filipino, 11.5, and
South Asian, 12.3. Paciﬁc Islanders had a
much higher incidence rate for MI at 18.5
(14.3–23.5). The rates were attenuated af-
ter adjustment for age and sex, but Paciﬁc
Islanders still had the highest incidence of
MI(10.1)ofallgroups.Theratesamongthe
other groups were Japanese, 3.3; Chinese,
3.6; Filipino, 4.7; South Asian, 5.9; and
Caucasians,5.9.Thesedifferencesamong
the among groups persisted with multi-
variate adjustment for several potential
explanatory factors.
The range of CHF unadjusted inci-
dence rates among the four Asian groups
was narrower than for MI (5.9–7.6), and
the aggregated rate of 7.0 was lower than
in Caucasians (13.0) and Paciﬁc Islanders
(9.2). Fully adjusted models showed no
signiﬁcant differences among these
groups compared with Caucasians. The
fully adjusted models for stroke showed a
similar pattern as with CHF.
For ESRD, aggregating the Asian
groups obscured the differences among
the groups. The age- and sex-adjusted rate
for the aggregate was 2.9 and slightly
higher than in Caucasians (2.4), but the
ratesrangedfrom1.1inSouthAsiansto3.9
in Filipinos. In Paciﬁc Islanders, the rate
was even higher (5.0). The fully adjusted
models showed higher rates than in Cau-
casians in all except for South Asians.
Asians had a ;60%lowerincidenceof
LEA compared with Caucasians or Paciﬁc
Islanders. The age- and sex-adjusted rates
rangedfrom0.7to1.3inAsians,compared
with 2.4 in Caucasians and 2.6 in Paciﬁc
Islanders. The fully adjusted models showed
similar differences.
In summary, the incidence rates in
Chinese, Japanese, and Filipinos were sim-
ilar for most complications in this cohort
with health care insurance. For the three
macrovascular complications, Paciﬁc
Islanders and South Asians had rates
similar to Caucasians. The incidence of
complicationsvarieddramaticallyamong
the Asian subgroups and highlights the
value of a more nuanced ethnic stratiﬁ-
cation for public health surveillance and
etiologic research.
TAILORING DIAGNOSIS,
PREVENTION, AND
TREATMENT TO
REFLECT ETHNIC DIFFERENCES
Diagnosis
Current criteria for the diagnosis of di-
abetes include fasting plasma glucose
$126 mg/dL, 2-h plasma glucose $200
mg/dL during an oral glucose tolerance
test (OGTT), a random plasma glucose
.200 mg/dL with classic symptoms,
and HbA1c of $6.5%. In a cross-sectional
study of Japanese Americans, OGTT as-
sessment of 503 individuals with normal
fasting glucose identiﬁed 176 with IGT
and 20 with glucose levels in the diabetic
range (22). These data raise the concern
that diagnosis by fasting glucose alone
fails to detect many Asian Americans
with abnormal glucose tolerance who
already have less favorable cardiovascu-
lar risk proﬁles. Similarly, the Diabetes
Epidemiology:CollaborativeAnalysisof
Diagnostic Criteria in Asia (DECODA)
study, involving 11 population-based
studies from Asia, showed that of
1,215 subjects diagnosed with diabetes
by fasting plasma glucose or OGTT,
only 449 met both criteria, a concor-
dance of 37% (23). Because impaired
fasting glucose (IFG) and IGT both
demonstrate some features of b-cell de-
fect and insulin resistance, but in differ-
ing degrees, the concordance between
the two categories is expected to be
limited (24).
In 2009, an international expert com-
mittee recommended the use of HbA1c
$6.5%asadiagnosticcriterionfordiabetes
Figure 2dDiabetes risk by weight change category in the Hawaii component of the Multi-
ethnicCohortStudy.ThereferencegroupisCaucasiansinthe25to+5kg(65)weightchange
category.
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Hsu and Associates(25). A study of Filipino Americans, Jap-
anese Americans, and Native Hawaiians
showedthatthesensitivityandspeciﬁcity
of HbA1c $6 . 5 % ,c o m p a r e dw i t hd i a b e -
tes deﬁned by OGTT, was 40.0 and
96.8%, respectively, and by fasting
plasma glucose was 68.9 and 95.3%, re-
spectively (26,27). These data indicate
using HbA1c alone as a diagnostic test
has high speciﬁcity but might delay the
diagnosis of type 2 diabetes among
AANHPIs.
T h e s ed i a g n o s t i cc o n s i d e r a t i o n s
are particularly signiﬁcant in Asian
Americans because they have higher
risks for diabetes, often present with-
out overt signs of obesity, and may be
misdiagnosed if a test with low sensi-
tivity is used. Although more cumber-
some and less replicable, the OGTT is
the most robust but underused diag-
nostic standard for diabetes in Asian
Americans.
Treatment
On the basis of clinical trials data and
collective clinicalexperience,theAmerican
DiabetesAssociation/EuropeanAssociation
for the Study of Diabetes and American
Association of Clinical Endocrinologists
have issued sets of recommendations
for initiating and adjusting therapy for
type2diabetes(28,29).Acriticismofthese
algorithmsdtheir failure to address funda-
mental pathophysiologydis especially rel-
evant to a discussion of the treatment of
diabetesinAANHPIs (30).The unique fea-
tures of diabetes pathophysiology among
subgroups within this very heterogeneous
population may indicate a need for differ-
ent treatment guidelines.
Moreover, the inherent methodo-
logic issues of collection, analysis, and
reportingofgranulardataintheAANHPI
populationmeansthatthereexisttoofew
AANHPI subjects in clinic trials to de-
termine the efﬁcacy or safety of glucose-
lowering drugs speciﬁc to the population
(31). Some have advocated borrowing
drug trial data from Asian countries in
lieu of obtaining data from the Asian
American population, but critics argue
that despite identical genetic makeup be-
tween Asians and Asian Americans, envi-
ronmental and epigenetic factors could
alter physiologic responses.
Given these deﬁciencies, there are
simply not enough data at present to
develop separate treatment guidelines
for this highly heterogeneous population.
Nonetheless, some cultural factors, such
as food, must be taken into account.
DIETARY GUIDELINES FOR
AMERICANS, 2010
(DGA 2010): CAN THEY
ACCOMMODATE ETHNIC
AND TRADITIONAL FOOD
PREFERENCES?dFood plays a signif-
icant role when considering the pre-
vention and treatment of diabetes in
AANHPIs. Food selection is often guided
by religious beliefs, folklore, food avail-
ability, taste, and varying approaches to
diet therapy. Environmental changes and
increased acculturation can have a nega-
tive impact on the weight and health of
AANHPIs (32,33).
The DGA 2010 (34)provide evidence-
based recommendations for individuals
aged 2 years and older that accommodate
the food preferences, cultural traditions,
and customs of the many diverse groups
in the U.S. The two overarching concepts
addressed in the guidelines are:
Maintain caloric balance over time to
achieve and sustain a healthy weight.
To control the obesity epidemic and pre-
vent associated risk factors, Americans are
advised to decrease their intake of calories
and increase physical activity. The strat-
egies recommended are: 1) monitor food
and beverage intake; 2) reduce portion
sizes;3) choose smaller portions or lower
calorie options when eating out; 4)u s e
food-preparation techniques that de-
crease fat intake such as baking, broiling
or sautéing with minimal amounts of un-
saturated oils in place of butter, ghee,
lard, coconut oil, and milk (sources of
saturated fatty acids), and trans-fats; and
5) limit television screen time. Although
food ingredients may differ according to
cultural practices, these recommenda-
tions are generally applicable to the
AANHPI population. As already noted,
the speciﬁc weight targets are lower for
Asian Americans.
Focus on consuming nutrient-dense
foods and beverages. Americans are ad-
vised to consume less sodium, fat, reﬁned
grains,sugar,andalcohol-containingfoods
and beverages and replace them with veg-
etables, fruits, whole grains, lean meats,
poultry without skin, seafood, very low-fat
dairy, beans and peas, nuts, and seeds. If
alcohol is consumed, the guidelines state
uptotwodrinksperdayformenandupto
one drink per day for women. To reduce
high blood pressure risk, the general recom-
mended sodium intake is #2,300 mg/day.
For individuals more sensitive to increased
sodium intake, the recommendation is to
loweritto1,500mg/day.Highsaltconsump-
tion is common in many Asian cultures
because many foods are pickled or pre-
served in salt or in high-sodium sauces;
therefore, the use of these condiments
should be reduced.
The U.S. Department of Agriculture’s
“MyPlate”isapracticaltooltohelpAmericans
make appropriate food choices and con-
trol portion sizes. MyPlate illustrates the
ﬁve food groups using a familiar meal-
time visual, a plate setting. In MyPlate,
half of the plate should be vegetables
and fruits and the other half allotted to
grains and proteins. An additional por-
tion of dairy is also recommended. The
limitation for this sizing approach is evi-
dent in some Asian cultures because
bowls or multiple plates are used in place
of one plate. Food is also often shared in
communal plates from which individuals
take bite sizes of food. These eating prac-
ticespresentmajorchallengestotraditional
teaching and counting of carbohydrates
(35). In addition, many Asians may be
more concerned with food texture, ﬂavor,
or aroma than what dietitians typically fo-
cus on such as the macronutrient compo-
sition or carbohydrate counting. AANHPIs
alsohavestrongbeliefsonthehealthfulness
of foods in health and disease (36). These
concepts are not familiar to Western cul-
ture. In summary, the principles outlined
inDGA2010areapplicabletotheAANHPI
community, but their practical implemen-
tation will require cultural adaptation.
DIABETES PREVENTIONdNo
study of diabetes prevention has been
speciﬁcally directed to Asians or Paciﬁc
Islanders in the U.S. However, a subset of
142 participants (4.4% of the cohort) in
the Diabetes Prevention Program (DPP)
was AANHPI(37). Althoughtheirsample
size was small, results among AANHPIs
are still worth noting. AANHPIs showed a
higher conversion rate per year in the pla-
cebo group of 12.1% versus 10.3% in Cau-
casians, despite lower mean weight and
BMI. However, compared with Caucasians,
AANHPI showed greater risk reduction
with lifestyle intervention (71% vs. 51%)
and metformin (38% vs. 24%). Assessment
of potential factors that could explain the
differences in conversion rates and risk re-
ductions, such as age, weight, physical ac-
tivity level, family history, and visceral
adiposity, could not be evaluated.
Other lifestyle intervention studies
among Asians have been performed in Asia,
and the results are reported in Table 1. Of
interest are the varied diabetes conversion
and intervention risk reduction rates among
these different populations (38–40).
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Pathophysiology and treatment in AANHPIsResponses to medication for diabetes
prevention, including differences in side
effects, also vary among Asians, perhaps
due to differences in diabetes pathophys-
iology. In contrast to the response among
AANHPI in the DPP, metformin failed to
show a large reduction of diabetes in-
cidence among Chinese and Indians
(41,42),althoughtheIndianDiabetesPre-
vention Programme showed that low-dose
metformin reduced diabetes incidence by
26%, similar to lifestyle intervention. In-
terestingly,theadditionofmetformintoa
lifestyle intervention failed to show fur-
ther risk reduction. Because of the Asian
custom of having high carbohydrate con-
sumption with each meal, addressing
postprandial hyperglycemia appears to
be a unique and effective intervention
amongAsians.Adiabetespreventionstudy
in Japan using an a-glucosidase inhibitor
showed a risk reduction of 58% (43).
Mixed results have been noted with the
use of thiazolidinediones. Pioglitazone did
notfurtherreducediabetesincidencewhen
addedtolifestyleinterventionintheIndian
Diabetes Prevention Programme, and rosi-
glitazone treatment among the Indian co-
hortoftheDiabetesREductionAssessment
with ramipril and rosiglitazone Medication
(DREAM) Trial showed less risk reduction
than other populations (40% vs. 60%)
(44,45).
COMMUNITY-BASED INTERVEN-
TION IN ASIAN INDIANSdAsian
Indians (AIs) in the U.S. and other west-
ernizedcountrieshavehighratesoftype2
diabetes (46). Insulin resistance is highly
prevalentinAImigrants,despitelowrates
of obesity (47). Increased urbanization
and socioeconomic and lifestyle transi-
tions are associated with the rapid rise of
type2diabetesinurbanandruralIndiaas
well as in AI immigrants to the U.S. (48).
Toassesstheprevalenceofdiabetesin
AIs living in the U.S., a study of 1,038
randomly selected AI adults was under-
taken at seven U.S. urban sites (46). Par-
ticipants were a mean age of 45.7 6 12.8
years, length of residence in the U.S. was
18.5 6 11.04 years, and BMI was 25.4 6
3.7kg/m
2.Most(60%)werenotvegetarian,
and 52% reported dietary acculturation
since moving to the U.S. Family history
of diabetes (siblings and parents) was
reported by 57%. The prevalence of dia-
betes was 17.4% (14.0% with known di-
abetes and 3.4% undiagnosed diabetes),
prevalence of prediabetes was 32.9%, and
prevalence of the metabolic syndrome, us-
ing International Diabetes Federation
criteria, was 38.2%. CVD risk factors were
also observed, including high levels of trigly-
cerides, total cholesterol, LDL cholesterol,
homocysteine, and C-reactive protein, and
low levels of HDL cholesterol.
Serving as a model for effective
community-based intervention, a 7-month
community-based participatory diabetes
prevention and management program
was initiated in South India (49). Trained
community health workers provided an
educational intervention to 703 village in-
habitants, consisting of adults and youth,
aged 10–92 years. Mean BMI in the adult
population was 20.6 6 3.8 kg/m
2;1 1 . 6 %
were overweight, and 16.4% were obese.
Mean daily caloric intake was 1,636.1 6
683.1 kcal in adults and 1,370.5 6 536.2
kcal in youth. High-risk participants were
provided one-on-one education and coun-
seling for blood glucose management by a
certiﬁed diabetes educator. Culturally and
linguistically appropriate health educa-
tionmessagesaddresseddiet,physicalac-
tivity, and knowledge of the disease. The
age-speciﬁc prevalences of diabetes and IFG
were5.1%and13.5%amongadultsand0%
and 5.1% among youth, respectively.
Intervention successfully reduced
fastingbloodglucoselevelsamongadults,
youth, and high-risk groups of IFG and
type 2 diabetes: 3% in the adults, 11% in
IFG adults, 17% in IFG youth, and 25%
among adults with type 2 diabetes. A sig-
niﬁcant reduction in all obesity param-
eters was also noted among adults and
IFGadults,andimprovementsindietary
ﬁber and protein also occurred among
adults (P = 0.001). Lower intake of dietary
ﬁber,highbloodpressure,andobesitysig-
niﬁcantly predicted higher blood glucose
levels (R
2 = 0.14, F = 4.54, P = 0.001).
Although the intervention did not change
dietary patterns in youth, there was an in-
crease in the knowledge level of the par-
ticipants (P = 0.013).
Thisstudyshowedthatacommunity-
based participatory approach to lifestyle
intervention successfully improved blood
glucose levels, ﬁber intake, and obesity
risk factors in rural India and may serve
as a prototype for similar programs among
AIs living in the US.
CULTURE-BASED DIABETES
EDUCATION AND SELF-
MANAGEMENT AMONG
NATIVE HAWAIIANS AND
PACIFIC ISLANDERSdDiabetes dis-
proportionately affects Paciﬁc people, such
asNativeHawaiians,whereprevalencerates
can be four times higher than in the general
U.S. population (50). Community organiza-
tions in collaboration with the University of
Hawaii’s Center for Native and Paciﬁc Health
Disparity Research developed innovative
diabetes self-management education pro-
grams that combine classroom teaching with
reconnectingparticipantstotheland.For
Paciﬁcpeople,relationshiptolandisadeep
andenduringpartoftheiridentity,history,
and spiritual beliefs. Paciﬁc Islanders, such
asNativeHawaiians,viewtheoriginofman
as arising from the land or from a product
of the land, metaphorically described as a
familial relationship between plants and
humans and a ﬁlial relationship humans
have with the land. The land is seen as the
provider of substance for the body and
spirit. Aloha ‘ aina ( l o v ef o rt h el a n d )i sar e -
curringthemeinthepoetry,dance,andmu-
sic of Paciﬁc people that can be traced back
at least 1,000 years.
Culture-based education is the ground-
ing of instruction in the values, norms,
knowledge, beliefs, practices, experiences,
and language of the students’ culture. Also
known as culturally responsive schooling,
it is a framework for teaching promoted
by educational scholars and indigenous
leaders for the past 40 years (51). The four
community-based health organizations in
Hawaii with diabetes educational programs
centered around reconnecting to the land
and values of aloha ‘ aina included three
community health clinics and a federally
established Native Hawaiian Health Care
System site.
The Healthy Eating and Lifestyle Pro-
gram (HELP) and Mai ka Mala‘ai (MALA)
are diabetes self-management classes for
Paciﬁcpeoplethatcombineclassroomed-
ucation with reconnecting to the land to
grow produce. The program participants
have type 2 diabetes and were referred by
their primary care physicians because of
poor self-management. Most participants
arefromPolynesianorMicronesianisland
groupsornations,includingHawaii,Tonga,
Samoa, Marshall Islands, and Chuuk. The
classroom curricula for each program, de-
veloped by each organization’sn u t r i t i o n i s t ,
were built around evidence-based ﬁndings
for diabetes self-care education. HELP is a
6-month program, with a monthly 2-h
classroom session and optional biweekly
communal gardening. MALA is a 10-week
program with weekly 90-min classroom
sessions and optional backyard gardening.
Both programs extensively incorporate as-
pects of culture-based education into their
curricula and teaching strategies.
Clinical measurements (weight, blood
pressure, HbA1c, and cholesterol) were
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Pathophysiology and treatment in AANHPIsmadebeforeandatthecompletionofeach
program. HbA1c showed a statistically sig-
niﬁcant decrease of 1.3% (P , 0.05), and
systolic blood pressure dropped 5.0
mmHg(P,0.05).Therewerenochanges
in cholesterol and weight. Both programs
created an environment of strong social
support, and mean retention of enrolled
participants was 81%.
The improvements in clinical and
metabolic parameters were attributed
to a combination of increase in practical
knowledge about diabetes management,
reduction of stress levels, and increase in
supportsystems.Themergingofpreferences
and practices appears to be an effective
way of reaching disparate populations.
Culture-based health education is very
appealing to ethnic communities because it
validatestheirculturalidentifyandheritage.
The appeal of a health education pro-
gram to participants is important for
enrollment and retention. A learning envi-
ronment must be created in which partic-
ipants feel comfortable and conﬁdent in
their ability to achieve success through
increased knowledge and appropriate
behavioral change.
A NATIONAL PROGRAM FOR
DIABETES PREVENTION
AND COMMUNITY
INTERVENTIONdThe NDEP (52)
wasestablishedin1997asafederallyfun-
ded program sponsored by the U.S. De-
partment of Health and Human Services’
National Institutes of Health (NIH) and
the Centers for Disease Control and Pre-
vention (CDC) and includes more than
200publicandprivatepartnersatthefed-
eral, state, and local levels. NDEP formed
an Asian American Paciﬁc Islander Work
Group (AAPI WG) in 1998 that has been
very active in developing and promoting
resources for AANHPI populations. A
new NDEP group is the Strategic Direc-
tions Group (SDG), essentially a “think
tank,” that will help with strategic plan-
ning. SDG membership includes repre-
sentatives from the National Council of
Asian Paciﬁc Islander Physicians, the As-
sociation of Asian PaciﬁcC o m m u n i t y
Health Organizations (AAPCHO), and
the Paciﬁc Chronic Disease Coalition.
The NDEPpartnershipfocusesonthe
use of education and communication ap-
proaches to address diabetes prevention
and control. It develops, tests, and dissem-
inates science-based, audience-tested and
-tailored, and culturally appropriate
resources for a wide range of audiences,
including people with and at risk for
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Hsu and Associatesdiabetes and their families, health care
providers, community-based lay work-
ers,businessesandworksites.Someofthe
resourcesontheimportanceofearlyglycemic
control, diabetes and heart disease, diabetes
self-management, and diabetes prevention
are available in 13–15 AANHPI languages.
To improve culturally appropriate outreach
to communities, CDC/NDEP fundedor-
ganizations serving ethnic/racial minority
communities: AAPCHO, National Asian
Women’s Health Organization, Khmer
Health Advocates, and Papa Ola Lokahi.
These organizations further adapted NDEP
materialsanddeterminedculturallyappro-
priate ways to reach the communities.
There are many other resources that
are relevant to AANHPI populations such
as tips for selecting foods at buffets, a
grocerylistforAsian foods,andarangeof
media articles. Materials for professionals
serving AANHPI populations also in-
cluded “Silent Trauma,” a white paper
for health care professionals, community
leaders, and policy makers. Its recom-
mendations deal speciﬁcally with issues
and barriers to refugees and include in-
formation on reducing the impact of di-
abetes in Southeast Asians in the U.S.
Another resource is the “Capacity Build-
ing Tool Kit,” based on AAPCHO’sA
Community Approach to Responding
E a r l y( C A R E )m o d e lu s i n gs t a g e so f
change and provides a framework to
help build diabetes outreach capacity in
community-based organizations serving
AANHPI population.
CONCLUSIONSdThe symposium
from which data from this review was
discussed (“Diabetes in Asian Americans,
NativeHawaiians,andPaciﬁcIslanders:A
Call to Action”)w a s“a call to action” to
addressdiabetesamongAANHPI popula-
tions and highlighted the speciﬁcd i f f e r -
ences, enormous diversity, and broad
challenges that face health care providers
as wellas patientswith diabetes(Table2).
With an emphasis on developing an ac-
tion plan and policy through evidence-
generated understanding of the problems
of diabetes within the AANHPI, general
consensus was attained on several items.
Firstandforemostistheneedforbetter
characterization of the burden of diabetes
and diabetes-related complications such as
ESRDandaccurateandcompletepopulation-
based data. A greater research effort and in-
creased funding should be provided to
improve our understanding of the differ-
ences in diabetes pathophysiology in
AANHPI.
Next is the need to enrich clinical
research with better representation by
AANHPI individuals. The current stand-
ards used by health care providers and
payers for diabetes management for the
AANHPI population are based on guide-
lines derived from clinical trials that did
not include very many AANHPI individ-
uals. Their disproportionately higher di-
abetes rates warrant the need for greater
inclusion of AANHPIs in research so that
results can be meaningfully interpreted.
Larger clinical trials should include mi-
nority groups beyond their national pop-
ulationrepresentationbecausethedisease
is disproportionately prevalent.
Anotherconsensuswasthatasidefrom
the need for more epidemiologic and clin-
ical data, our current understanding of
diabetes in AANHPIs should be resonated
acrossthecountry.ManyAANHPIpatients
with diabetes receive their care from non-
AANHPI physicians. Health care providers
need to be informed about the physiologic
and cultural characteristics of diabetes in
this population: diabetes risk may be asso-
ciated with lower BMI and weight; the as-
sociation of smaller degrees of visceral
adiposity with greater insulin resistance
and metabolic syndrome; higher carbohy-
drateconsumptionrequiresgreaterneedto
address postprandial hyperglycemia; and
various cultural barriers to therapy and
nutritional recommendations.
Aﬁnaloutcomefromthissymposium
was the importance and effectiveness of
community-based interventions. The di-
versity among AANHPIs precludes the
use of any “one shoe ﬁts all” recommen-
dation or intervention. Improving diabe-
tes care and reducing risk factors that
contribute to diabetes and diabetes com-
plications need to be tailored and made
speciﬁc to a given population. The two
contrastinginterventionsinIndiaandNa-
tive Hawaiian communities demonstrate
theeffectivenessof“includingthepeople”
in their own care. Developing these pro-
grams may be an enormous and poten-
tially complex undertaking, given the
diversity of communities within the
AANHPI population, but could ultimately
result in cost-saving. An example is diabe-
tes prevention. It is clear from all the avail-
able clinical trials and translational efforts
among AANHPIs that lifestyle intervention
directed toward weight loss and increasing
physical activities will reduce diabetes in-
cidence. An AANHPI initiative that targets
lifestyle intervention in at-risk individuals
and offered through community-based
programs should be seriously considered
as a priority within a national program for
reducing the burden of diabetes.
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Table 2dSuggested next steps from the Symposium
1. More accurately characterize the burden of diabetes and diabetes-related complications
based on complete and population-based data for AANHPIs
2. Enrich clinical research with more representation by AANHPI individuals
3. Educate health care providers across the country about the current understanding of the
pathophysiology and cultural factors associated with diabetes in AANHPIs
4. Develop more community-based diabetes prevention or intervention programs and
tailor diabetescareto theAANHPIcommunitythroughaculturally effective approach
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